New Zealand’s clin neg panacea is no such thing
The non-adversarial model used in New Zealand is held up as a better way of resolving clinical negligence claims. But is it really an improvement?
Success of 'bold' reforms too early to call
The Ministry of Justice predicted that extending fixed recoverable costs would make legal costs ‘more certain and predictable’. So far, it appears the opposite has happened.
Why Mazur is 'interfering with play'
According to Andrew Roy KC, the offside rule is how we need to think of things in the post-Mazur world.
Demystifying AI
Rachel Rothwell reviews 'Andrew and the Marvellous Analytical Engine' by Andrew Hogan.
A new costs war begins
Paying parties have wasted no time in citing Mazur in their points of dispute.
Clipping the wings of class action lawyers
Claimant lawyers will protest that the collective actions regime is still in its infancy and it is too soon for change. They may find themselves shouting into the wind.
CAT steps up scrutiny of collective action fees
There is never a dull moment in the collective actions sphere.
- Previous
- Next
